Drug Discovery

share

Researchers at the Centenary Institute at the University of Sydney have advanced the development of a new class...

share

Cancer Research UK’s Drug Discovery Committee is awarded an additional £5m to Newcastle University’s Northern Institute of Cancer...

share

Positive results of Symbiomix Therapeutics' first pivotal trial for lead drug candidate SYM-1219, a single-dose, oral product candidate...

share

Eisai and Halozyme Therapeutics have agreed to evaluate the combination of their drugs, Halaven (eribulin) and PEGPH20 (PEGylated...

share

Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement to conduct a Phase...

share

Switzerland-based Drugs for Neglected Diseases initiative (DNDi) and Takeda Pharmaceutical have signed an agreement to collaborate in the...

share

Australian drug development company Invion has secured a commitment from Hovione Scientia Limited, an international pharmaceutical company expert...

share

Akashi Therapeutics a clinical stage biopharmaceutical company developing treatments for Duchenne muscular dystrophy (DMD), announced positive interim clinical...